Last edition
News about "Evogene "
Lishan Biotech secures exclusive worldwide rights to develop and commercialise BMC128, a Phase I microbiome-based immunotherapy candidate showing early promise in lung and renal cancers.
Evogene | 07/02/2026 | By News Bureau | 106
Evogene Appoints Dr Olga Nissan as VP for Business Development
Evogene has appointed Dr Olga Nissan as Vice President of Business Development, effective 1 January, 2026, bringing to the role a seasoned biotechnology and pharmaceutical leader with extensive experience spanning R&D, clinical development and business operations across pharma, diagnostics and agri-biotechnology sectors.
Evogene | 31/12/2025 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy